ROBERT W. ROSS - 21 Jul 2021 Form 4 Insider Report for Surface Oncology, Inc.

Role
Chief Executive Officer
Signature
/s/ Jessica Fees, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
21 Jul 2021
Net transactions value
-$204,350
Form type
4
Filing time
14 Jan 2022, 19:30:27 UTC
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SURF Common Stock Sale $204,350 -33,500 -38% $6.10* 54,500 21 Jul 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amount reported represents the number of shares sold by the reporting person to cover the tax withholding obligations in connection with the vesting of restricted stock units.